CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 1 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,759,289
+125.3%
940,796
+202.4%
0.00%
Q2 2023$780,786
+2959.9%
311,070
+2033.4%
0.00%
Q1 2023$25,517
-60.3%
14,581
-3.5%
0.00%
Q4 2022$64,226
-57.5%
15,112
-75.4%
0.00%
Q1 2022$151,000
+1.3%
61,313
+11.4%
0.00%
Q4 2021$149,000
-46.0%
55,0330.0%0.00%
Q3 2021$276,000
-22.5%
55,033
+15.5%
0.00%
Q2 2021$356,00047,6480.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders